433 / 1631
Rationale for RT for R/R cHL
•
HL is one of the most
radiosensitive
human malignancies
•
Local control
after RT is high
•
Large proportion of relapses
(
and by definition refractory disease)
is in
previous
sites
•
Most studies of combined treatment in lymphoma shows
benefit
for
addition of RT (PFS - ?OS)
•
Benefit / late effects
balance
is different in ref/rel situations